Chan Zuckerberg Initiative

Chan Zuckerberg Initiative joins Philanthropic and Community Partners to Discuss Innovative Solutions to Solving Bay Area's Housing Affordability Crisis

Retrieved on: 
Thursday, April 4, 2024
PBF, Organization, LISC, CFI, AMI, CZI, SAN, City, San Francisco Foundation, Policy, Family, Chan Zuckerberg Initiative, Silicon Valley Community Foundation, Silicon, Housing, Investment, The Commonwealth Club, Commonwealth Club, Government, Work, Management

It brings a variety of voices into the effort ― from local governments, to non-profit and community advocacy partners and faith leaders.

Key Points: 
  • It brings a variety of voices into the effort ― from local governments, to non-profit and community advocacy partners and faith leaders.
  • "The housing crisis requires bold action on multiple fronts and it requires that all sectors come to the table to drive innovative solutions," said Fred Blackwell, CEO, San Francisco Foundation.
  • "Safe, stable, and affordable housing is crucial to a family's success and to building healthy and diverse communities," said Priscilla Chan, co-founder and co-CEO of the  Chan Zuckerberg Initiative.
  • Five years in, we've surpassed our fundraising goal and deployed that capital to provide housing for thousands of bay area residents."

CZI Launches AI Advisory Group and Residency Program to Accelerate Development of Virtual Cell Models

Retrieved on: 
Thursday, March 21, 2024
Research, Health, McGill University, Faculty, Organization, OpenAI, Human Protein Atlas, Computer science, CZI, Associate, Disease, Meta, AI, Chan Zuckerberg Initiative, Biology, Harvard University, Former, Nature, Partner, Stanford University, Biological engineering, Artificial intelligence, Medical device

REDWOOD CITY, Calif., March 21, 2024 /PRNewswire/ -- Today, the Chan Zuckerberg Initiative (CZI) announced several key appointments and a new AI residency program to advance the organization's AI strategy for science, which is focused on building predictive models of healthy and diseased cells. Several AI experts from academia and industry have joined a newly established AI Advisory Group, which will provide guidance to leaders at CZI and across the Chan Zuckerberg Biohub Network as these organizations work to enable AI at scale for nonprofit life science research. In addition, CZI is launching an AI residency program to develop foundational AI/ML models and tools that will enable new scientific breakthroughs. Theofanis Karaletsos, a technology leader in AI/ML research and science, has also been hired as CZI's Head of Artificial Intelligence for Science.

Key Points: 
  • In addition, CZI is launching an AI residency program to develop foundational AI/ML models and tools that will enable new scientific breakthroughs.
  • These advisors have deep expertise in leveraging AI/ML models and methods to advance scientific research:
    Sam Altman, CEO of OpenAI.
  • Karaletsos will lead CZI's AI strategy for science, including the organization's vision to develop virtual cell models, utilizing one of the largest high-performance AI computing system s for nonprofit life science research.
  • He will collaborate with scientific leaders at CZI including Emma Lundberg, a member of CZI's AI Advisory Group and an Associate Professor of Bioengineering at Stanford University, to launch an in-house AI Residency Program.

Scholastic Appoints Alix Guerrier and Kaya Henderson to its Board of Directors

Retrieved on: 
Thursday, March 21, 2024
Principal, Common stock, Culture, McKinsey & Company, Education, Foreign Service, Physics, Master, Growth, Leadership High School, Edgenuity, Science, Pan American School, Superintendent, Georgetown University, School, Chairperson, Humanities, Trinity Washington University, Policy, Literacy, The New Teacher Project, Head, Chan Zuckerberg Initiative, Educational technology, Scholastic, GlobalGiving, MBA, Student, DonorsChoose, Harvard University, Curriculum, Partner, Stanford University, Management

NEW YORK, March 21, 2024 /PRNewswire/ -- Scholastic (NASDAQ: SCHL), the global children's publishing, education and media company, today announced that Alix Guerrier and Kaya Henderson were appointed to its board of directors (the "Board") as independent directors, effective March 20, 2024.

Key Points: 
  • NEW YORK, March 21, 2024 /PRNewswire/ -- Scholastic (NASDAQ: SCHL), the global children's publishing, education and media company, today announced that Alix Guerrier and Kaya Henderson were appointed to its board of directors (the "Board") as independent directors, effective March 20, 2024.
  • Mr. Guerrier contributes over 20 years of experience in the education sector including as a teacher and an educational technology entrepreneur.
  • Ms. Henderson currently serves as Chief Executive Officer of Reconstruction US, a technology company she co-founded and launched in April 2020.
  • Before serving in her current role, Ms. Henderson served as Principal for her consulting company, Kaya Henderson Consulting.

Homeworld Collective Awards $1.3M in Funds to 16 New Climate Biotech Projects with New Approach to Grantmaking

Retrieved on: 
Tuesday, March 12, 2024
Schmidt Futures, Climate change, Biotechnology, Growth, Science, Knowledge, Attitude, Chan Zuckerberg Initiative, Carbon, Thought, Biology, Organizational founder, Optimism, Mining, Renewable energy

CAMBRIDGE, Mass., March 12, 2024 /PRNewswire-PRWeb/ -- Today, Homeworld Collective, a thriving community of biotechnologists working on planetary-scale problems, announced that they have awarded $1.3M in funds to 16 new biotechnology projects focused on solving pressing climate-related problems through their Garden Grants program. Having received funding from leading philanthropies including Schmidt Futures and Grantham Foundation, the organization had originally planned to award $1M in grants. The quality and rigor of the submissions inspired Homeworld philanthropic supporters to increase the funding pool to $1.3M.

Key Points: 
  • The inaugural Garden Grants program is showing early success in mobilizing bioengineers towards climate work and roadmapping key problems to solve in climate biotech.
  • "We were thrilled," said Paul Reginato, Science Director and Cofounder of Homeworld Collective, "that 50% of the applications were from applicants exploring climate biotech for the first time.
  • Homeworld, at its core, is a community, and seeks to strengthen the field of climate biotech in whatever way possible."
  • Homeworld Collective was founded with the mission to address this issue, grow the field of climate biotechnology, and accelerate the development and deployment of gigaton-scale climate solutions.

Every Cure to Receive $48.3M from ARPA-H to Develop AI-Driven Platform to Revolutionize Future of Drug Development and Repurposing

Retrieved on: 
Wednesday, February 28, 2024
Master of Science, ARPA, Chan Zuckerberg Initiative, ALS, Extension, AI, MD, Intelligence, Physician, FDA, Pennsylvania State University, Flagship Pioneering, DARPA, Drug discovery, Government, MBA, University, White, Spectrum, Entrepreneurship, Semaglutide, Arginine, Organization, Associate, Sickle cell disease, Patient, Disease, NCATS, MATRIX, Research, Pharmaceutical industry

NEW YORK, Feb. 28, 2024 /PRNewswire/ -- Every Cure, a nonprofit on a mission to save lives by repurposing existing medicines, announced today significant funding from the Advanced Research Projects Agency for Health (ARPA-H). The three-year, $48.3 million contract was unveiled at the White House this evening and represents a substantial federal investment in drug repurposing. It will accelerate Every Cure's mission to unlock the full potential of existing drugs to treat more diseases through the development of an AI-powered platform, called ML/AI-enabled Therapeutic Repurposing In eXtended uses (MATRIX).

Key Points: 
  • The three-year, $48.3 million contract was unveiled at the White House this evening and represents a substantial federal investment in drug repurposing.
  • "I'm alive and in remission from my rare disease thanks to a repurposed drug that I discovered.
  • "Through Every Cure, we are working tirelessly to unlock the full potential of FDA-approved drugs to treat many more diseases.
  • The ARPA-H funding will enable Every Cure to:
    Develop an open-source drug repurposing database.

The HBCU Executive Leadership Institute Announces New Investment from Chan Zuckerberg Initiative

Retrieved on: 
Friday, February 16, 2024
Chan Zuckerberg Initiative, HBCU, Student, Bennett College, Education, Clark Atlanta University, Curriculum, Black, CAU, Partnership, Management

ATLANTA, Feb. 16, 2024 /PRNewswire/ -- Continuing its commitment to building the next generation of HBCU legacy leaders, the HBCU Executive Leadership Institute  (ELI) at Clark Atlanta University, today announced its receipt of a grant for $1.2 million from the Chan Zuckerberg Initiative. The grant includes funding to expand ELI's curriculum, which offers micro-credentials and prepares executives to assume leadership positions in higher education.

Key Points: 
  • ATLANTA, Feb. 16, 2024 /PRNewswire/ -- Continuing its commitment to building the next generation of HBCU legacy leaders, the HBCU Executive Leadership Institute (ELI) at Clark Atlanta University, today announced its receipt of a grant for $1.2 million from the Chan Zuckerberg Initiative.
  • The Chan Zuckerberg Initiative was a founding sponsor of the ELI program when it first launched in 2021.
  • The program identifies and develops the most qualified candidates to fill vital HBCU presidencies and other executive leadership positions.
  • "We are grateful to the Chan Zuckerberg Initiative for their partnership as ELI continues to cultivate Fellows and help our HBCUs prosper."

Carnegie Foundation Welcomes Brooke Stafford-Brizard as Vice President for Innovation and Impact

Retrieved on: 
Wednesday, January 17, 2024
Student, Learning, Research, Foundation (nonprofit), Carnegie Foundation, Aspen Institute, Science, School, Cognitive science, Education, Chan Zuckerberg Initiative, Columbia University, Doctor of Philosophy, Management

STANFORD, Calif., Jan. 17, 2024 /PRNewswire/ -- The Carnegie Foundation for the Advancement of Teaching (Carnegie) is pleased to announce that Brooke Stafford-Brizard will join the organization as vice president for innovation and impact.

Key Points: 
  • STANFORD, Calif., Jan. 17, 2024 /PRNewswire/ -- The Carnegie Foundation for the Advancement of Teaching (Carnegie) is pleased to announce that Brooke Stafford-Brizard will join the organization as vice president for innovation and impact.
  • As vice president at Carnegie, Stafford-Brizard will leverage her multifaceted career to cultivate and steward cross-sector partnerships to accelerate the foundation's mission.
  • "Brooke embodies our commitment to catalyzing transformational change in education by fostering innovative, evidence-based practices," said Timothy F.C.
  • Most recently, Stafford-Brizard served as vice president for research to practice at the Chan Zuckerberg Initiative.

Employer Direct Healthcare (EDH) Announces $92 Million Investment from Insight Partners, $1 Billion Valuation

Retrieved on: 
Tuesday, December 19, 2023
Insight Partners, Oncology, WTW, AutoZone, CVS, Government, EDH, GM, Fortune 500, CMO, 1Life Healthcare, Surgeon, HRIS, Chan Zuckerberg Initiative, Cancer, Health, Insight, Insurance, Pulse, National accounts, SVP, Public sector, Compensation, Management

DALLAS, Dec. 19, 2023 /PRNewswire/ -- Employer Direct Healthcare (EDH), a leading specialty healthcare network solution, today announced a $92 million secondary investment from global software investor Insight Partners, bringing the company's valuation to $1 billion. EDH's existing institutional investors, Serent Capital, Redmile Group and Dundon Capital, will maintain their ownership interest in the business. 

Key Points: 
  • Secondary investment in recognition of EDH's leading market position, strong fundamentals, and world-class leadership team
    DALLAS, Dec. 19, 2023 /PRNewswire/ -- Employer Direct Healthcare (EDH), a leading specialty healthcare network solution, today announced a $92 million secondary investment from global software investor Insight Partners, bringing the company's valuation to $1 billion.
  • EDH's existing institutional investors, Serent Capital, Redmile Group and Dundon Capital, will maintain their ownership interest in the business.
  • While doing so, EDH has lowered overall healthcare costs for employer clients by a total of ~$700 million since inception and will reduce overall healthcare costs for clients by approximately 2% in 2023.
  • "We're grateful for Insight Partners' significant vote of confidence as we continue to deliver excellent, affordable, and accessible specialty care for more communities.

Cambiar Thrive Grant Awards $3 Million to Cutting-Edge Organizations Providing Families With Student Data and Insights

Retrieved on: 
Wednesday, November 15, 2023
Organization, SAN, Chan Zuckerberg Initiative, Love, Learning, Student, Sí Se Puede Cambiar, Caregiver, COVID-19, Parent, School, University, Partnership, Communication, Growth, App Store (iOS/iPadOS), Tutoring, Thrive

The Cambiar Thrive Grant awarded a total of $3 million in the amounts of $50,000 - $250,000 to 31 grantees, representing a range of organizations, leaders, communities, and ideas.

Key Points: 
  • The Cambiar Thrive Grant awarded a total of $3 million in the amounts of $50,000 - $250,000 to 31 grantees, representing a range of organizations, leaders, communities, and ideas.
  • Ninety percent of the grantees serve families of color and high-need populations, including low-income, disadvantaged, and multilingual learners.
  • The Cambiar Thrive Grant aims to address the increasing demand and need to provide parents and caregivers with academic and non-academic information about their children.
  • Those will be key learnings we can use as we continue to transform parent engagement and advance data equity,” said Nick Kind, Managing Director, Tyton Partners.

ImmunoScape Appoints Systems Immunology and Computational Biology Expert Dr. John Tsang to its Scientific Advisory Board

Retrieved on: 
Tuesday, December 12, 2023
Science, Other Science, Biotechnology, Research, Pharmaceutical, Oncology, General Health, Health, Biophysics, NIAID, TCR, Organization, Allen Institute, Executive Committee, National Cancer Institute, Cell Reports, University, Chan Zuckerberg Initiative, Master of Mathematics, Multimedia, Computational biology, Systems biology, Biomedicine, Allele, SAB, Machine learning, HLA, COVID-19, Kidney, Therapy, Intramural sports, NIH, World Allergy Organization, Cancer, Bangladesh Technical Education Board, CHI, Harvard University, Biomedical engineering, System, Digestive, Bachelor of Applied Science, Infection, Medical device, Management, Yale University, Columbia

ImmunoScape , a biotechnology company focused on next-generation immunotherapies, today announced the appointment of John Tsang, Ph.D. to its Scientific Advisory Board (SAB).

Key Points: 
  • ImmunoScape , a biotechnology company focused on next-generation immunotherapies, today announced the appointment of John Tsang, Ph.D. to its Scientific Advisory Board (SAB).
  • Dr. Tsang joins a distinguished group of leading scientists in immunology and oncology who help to guide ImmunoScape’s scientific strategy.
  • Dr. Tsang was also the Co-Director of the Trans-NIH Center for Human Immunology (CHI) and led its research program in systems human immunology.
  • Dr. Tsang has won multiple awards for his research, including several NIH/NIAID Merit Awards recognizing his scientific leadership in systems immunology, COVID-19, and human immunology research.